ORIENTBIO Inc. Total Liabilities
ORIENTBIO Inc. total liabilities. Based on the latest financial reports, ORIENTBIO Inc. (002630) has total liabilities worth ₩12.64 Billion KRW (≈ $8.57 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 002630 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of ORIENTBIO Inc. (2006–2025)
Total liabilities of ORIENTBIO Inc. from 2006 to 2025. This chart illustrates how ORIENTBIO Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore 002630 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
ORIENTBIO Inc. Competitors by Total Liabilities
The table below lists competitors of ORIENTBIO Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Buligo Capital Ltd
TA:BLGO
|
Israel | ILA19.11 Million |
|
Star Holdings
NASDAQ:STHO
|
USA | $304.33 Million |
|
Tile Shop Holdings Inc
NASDAQ:TTSH
|
USA | $214.49 Million |
|
Melnick Even Desenvolvimento Imobiliário S.A
SA:MELK3
|
Brazil | R$1.59 Billion |
|
Edimax Technology Co Ltd
TW:3047
|
Taiwan | NT$3.28 Billion |
|
Surge Copper Corp
V:SURG
|
Canada | CA$6.01 Million |
|
Viet Dragon Securities Corp
VN:VDS
|
Vietnam | ₫4.89 Trillion |
|
PannErgy Nyrt.
F:PPL
|
Germany | €15.22 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down ORIENTBIO Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of ORIENTBIO Inc..
Liquidity & Leverage Metrics
ORIENTBIO Inc. Total Liabilities Ratios Explained
ORIENTBIO Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 11.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ORIENTBIO Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ORIENTBIO Inc. (2006–2025)
The table below shows the annual total liabilities of ORIENTBIO Inc. from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₩12.94 Billion ≈ $8.77 Million |
+8.77% |
| 2024-03-31 | ₩11.89 Billion ≈ $8.06 Million |
+23.13% |
| 2023-03-31 | ₩9.66 Billion ≈ $6.54 Million |
-55.63% |
| 2022-03-31 | ₩21.76 Billion ≈ $14.75 Million |
-5.26% |
| 2021-03-31 | ₩22.97 Billion ≈ $15.57 Million |
+14.05% |
| 2020-03-31 | ₩20.14 Billion ≈ $13.65 Million |
-6.06% |
| 2019-03-31 | ₩21.44 Billion ≈ $14.53 Million |
-80.53% |
| 2018-03-31 | ₩110.11 Billion ≈ $74.62 Million |
+47.44% |
| 2017-03-31 | ₩74.68 Billion ≈ $50.61 Million |
-11.47% |
| 2016-03-31 | ₩84.35 Billion ≈ $57.16 Million |
+3.61% |
| 2015-03-31 | ₩81.42 Billion ≈ $55.17 Million |
+4.67% |
| 2014-03-31 | ₩77.78 Billion ≈ $52.71 Million |
+5.18% |
| 2013-03-31 | ₩73.95 Billion ≈ $50.12 Million |
+17.33% |
| 2012-03-31 | ₩63.03 Billion ≈ $42.72 Million |
+225.32% |
| 2011-03-31 | ₩19.38 Billion ≈ $13.13 Million |
-54.46% |
| 2010-03-31 | ₩42.55 Billion ≈ $28.83 Million |
+4.85% |
| 2009-03-31 | ₩40.58 Billion ≈ $27.50 Million |
-9.68% |
| 2008-03-31 | ₩44.93 Billion ≈ $30.45 Million |
+60.37% |
| 2007-03-31 | ₩28.02 Billion ≈ $18.99 Million |
+16.95% |
| 2006-03-31 | ₩23.96 Billion ≈ $16.24 Million |
-- |
About ORIENTBIO Inc.
ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformati… Read more